Career Opportunities in 2025–2026: Positioning Yourself for Model-Informed Roles

Model-Informed Drug Development

As 2025 comes to a close and the industry prepares for 2026, one trend is unmistakable: model-informed drug development continues to reshape the biopharma landscape.

Breakthroughs in biologics, gene therapies, mRNA platforms, and rare disease programs are accelerating the demand for scientists who can bridge computation, biology, and clinical translation. The need for QSP, Pharmacometrics, DMPK, PBPK, and Clinical Pharmacology expertise is stronger than ever, and it’s only intensifying in 2026.

The dynamic is clear: Scientific innovation is growing faster than the talent pool.

For candidates in modeling and simulation disciplines, this creates a rare window of opportunity at the end of 2025 and into 2026: more influence, more strategic roles, tightening flexibility, and more competition among employers for top-tier scientific talent.

Learn more about our role in supporting modeling & simulation professionals.

The New Talent Landscape: What It Means for You Heading into 2026

While employers face mounting pressure to secure modeling and simulation talent, these challenges translate directly into an advantage for scientists with the right expertise and positioning.

Below are the key shifts that will define your opportunities in late 2025 and throughout 2026:

1. The Rise of Hybrid Scientists

Organizations are prioritizing professionals who combine:

  • Quantitative modeling expertise (PK/PD, PopPK, QSP, PBPK, M&S)
  • Biological, translational, or clinical understanding
  • The ability to tie model outputs to strategic decision-making

This hybrid profile is becoming the gold standard for 2026 hiring, especially as pipelines become more complex and regulatory expectations evolve.

How to position yourself for 2026:

  • Showcase cross-functional impact, not just modeling tasks.
  • Highlight projects where your work shaped decisions: dose selection, trial design, go/no-go, benefit–risk evaluations.
  • Demonstrate breadth across modalities or disease areas where possible.

2. Demand Will Continue to Outpace Supply in 2026

The gap between industry needs and available talent widened in 2024–2025 and is expected to widen further in 2026.

This means:

  • More roles created across early development, translational, and late-stage teams
  • More companies are competing for the same small pool of highly skilled scientists

What this means for you:

You’ll enter 2026 with leverage across compensation, role scope, varying flexibility, and long-term growth opportunities.

How to position yourself:

  • Be ready with a clearly defined career direction for 2026.
  • Update your CV to reflect recent achievements and model-informed impact.
  • Maintain visibility within specialized networks and scientific communities.

Share your CV for tailored opportunities in 2025–2026.

3. Communication Skills Become Even More Critical in 2026

Teams are increasingly looking for scientists who can engage with Clinical, Regulatory, Development, and senior leadership, not just other modelers.

In 2026, hiring teams will prioritize individuals who can:

  • Articulate modeling outputs to non-technical audiences
  • Influence decisions at governance meetings
  • Represent the modeling strategy in regulatory interactions

How to position yourself:

  • Emphasize communication-driven accomplishments on your CV.
  • Prepare examples that show your ability to align stakeholders or guide decision-making.
  • Demonstrate how your insights supported the cross-functional strategy.

4. Retention Challenges Create New Career Mobility

Many companies still lack mature career frameworks for MIDD disciplines. This leads to a bottleneck and creates opportunities for scientists seeking roles with clearer growth paths going into 2026.

How to position yourself:

  • Prioritize organizations where modeling is embedded early in decision-making.
  • Ask about career paths, leadership opportunities, and scientific recognition.
  • Evaluate whether the team structure supports visibility and long-term development.

Turning 2025–2026 Market Dynamics Into Career Advantage

As modeling becomes more influential across development, scientists who understand how to align technical work with strategic outcomes will stand out in 2026.

Model-informed roles provide the opportunity to:

  • Shape early and late-stage decisions
  • Reduce clinical risk
  • Strengthen regulatory submissions
  • Accelerate timelines across therapeutic areas
  • Increase cross-functional cohesion

In a competitive market, being able to articulate these contributions clearly is what sets high-performing candidates apart.

Discover how we help candidates highlight their impact and advance their careers.

How to Stand Out as a Modeling & Simulation Professional in 2025–2026

1. Update your CV for 2026 hiring cycles.

Focus on impact, decision-making influence, and cross-functional integration.

2. Reinforce your presence in scientific networks.

Visibility matters, especially in niche fields like QSP, Pharmacometrics, and DMPK.

3. Identify your 2026 priorities early.

Role scope, leadership ambitions, preferred modalities, and desired environment.

4. Connect with domain-specialized recruiters.

Many 2026 openings, especially in modeling, are never publicly advertised.

Partnering with Hughes & Associates: Elevate Your Career in 2026

For over two decades, Hughes & Associates has specialized in life sciences recruitment with deep expertise across:

  • Clinical Pharmacology
  • Pharmacometrics
  • QSP
  • DMPK and ADME
  • PBPK, PK/PD, and MIDD roles
  • Bioanalysis and related quantitative disciplines

We work closely with leading biotech and pharma organizations on the upcoming 2025–2026 hiring plans. Because of this, we often see strategic roles before they’re published, and many are exclusively shared with us.

How We Support Your 2025–2026 Career Goals

We understand the science.
Our conversations with you are grounded in your technical domain, not generic recruiting language.

We introduce you to the right roles at the right time.
Especially as companies begin planning their 2026 hiring pipelines.

We prioritize long-term fit.
We’ll help you evaluate roles not only for today, but for where you want your career to be in two to five years.

We maintain full confidentiality.
Critical for senior and specialized scientists evaluating new opportunities.

Start the 2026 Hiring Cycle with Clarity and Confidence
If you’re exploring new opportunities or simply assessing your market position, now is an ideal moment to begin planning your 2025–2026 career path.

Share your CV or schedule a confidential conversation with our SVP, Jay Chapman.
📩 jchapman@haallc.com
📞704-264-5203

Whether you’re ready for your next move or simply curious about how 2026 hiring trends may impact your trajectory, Hughes & Associates can provide a clear, strategic view of the market.

Stay ahead. Build a stronger path.
Make 2026 the year your impact grows even further.

🔗 Connect with us for upcoming insights and opportunities in QSP, Pharmacometrics, Clinical Pharmacology, and DMPK:

LinkedIn | Facebook | Instagram | X | YouTube

Your next breakthrough or next career step may be just one conversation away.

Read More:
The Demand for DMPK Scientists: How to Position Yourself for Career Success in 2025
How to Build a Successful Career in Pharmacometrics: Skills, Jobs, and Growth Opportunities
How to Advance Your Career in Clinical Pharmacology: 2025 Job Market Insights


Leave a Reply

Your email address will not be published. Required fields are marked *